about
Long-term outcomes in thoracoabdominal aortic aneurysm repair for chronic type B dissection.Health-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study.Lung cancer staging: a physiological update.Outcomes and predictors of prolonged ventilation in patients undergoing elective coronary surgery.Liverpool Aortic Surgery Symposium V: New Frontiers in Aortic Disease and SurgeryInfluences on Early and Medium-Term Survival Following Surgical Repair of the Aortic Arch.Is single-unit blood transfusion bad post-coronary artery bypass surgery?Repair of type A dissection-benefits of dissection rota.External validity of the Society of Thoracic Surgeons risk stratification tool for deep sternal wound infection after cardiac surgery in a UK populationA Perspective on Natural History and Survival in Nonoperated Thoracic Aortic Aneurysm Patients.Aortic Valve Repair: A Systematic Review and Meta-analysis of Published Literature.Unwarranted Variation in the Quality of Care for Patients With Diseases of the Thoracic Aorta.Virchow's triad and intestinal ischemia post cardiac surgery.Construction and validation of a plaque discrimination score from the anatomical and histological differences in coronary atherosclerosis: the Liverpool IVUS-V-HEART (Intra Vascular UltraSound-Virtual-Histology Evaluation of Atherosclerosis RequirinDevelopment and Validation of Elective and Nonelective Risk Prediction Models for In-Hospital Mortality in Proximal Aortic Surgery Using the National Institute for Cardiovascular Outcomes Research (NICOR) Database.Secondary Open Aortic Procedure Following Thoracic Endovascular Aortic Repair: Meta-Analytic State of the Art.The impact of social deprivation on coronary revascularisation treatment outcomes within the National Health Service in England and Wales.Halting the spread of epidemic pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study.Long-term survival of patients with pulmonary disease undergoing coronary artery bypass surgery.Long-term survival of non-smokers undergoing coronary artery bypass surgery.Atrial fibrillation postcardiac surgery: a common but a morbid complication.Red cell distribution width and coronary artery bypass surgery.How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery.Acute type A aortic dissection in the United Kingdom: Surgeon volume-outcome relation.Propensity score-matched outcomes after thoracic epidural or paravertebral analgesia for thoracotomy.Preoperative point-of-care platelet function testing in cardiac surgery.A comparison of fibrinogen measurement using TEG(®) functional fibrinogen and Clauss in cardiac surgery patients.Intra- and inter-centre standardisation of thromboelastography (TEG®).Prospective use of Ablation Index targets improves clinical outcomes following ablation for atrial fibrillation.Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial.Long-term survival after coronary artery bypass surgery stratified by EuroSCORE.Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.The effect of patient sex on survival in patients undergoing isolated coronary artery bypass surgery receiving a radial artery.Female sex and long-term survival post curative resection for non-small-cell lung cancer.Pneumonectomy: risk factor or innocent bystander?The impact of diabetes mellitus on two-year mortality following contemporary percutaneous coronary intervention: implications for revascularization practice.Clinical predictors of informative genetic testing in hypertrophic cardiomyopathyUse of Ablation Index-Guided Ablation Results in High Rates of Durable Pulmonary Vein Isolation and Freedom From Arrhythmia in Persistent Atrial Fibrillation Patients
P50
Q34028745-55513A5E-E379-4D39-82CB-5D2AAEBFEA58Q35793872-05BEDD43-28FA-41C5-A220-017FDF7ED262Q35961771-10D5F284-ECAE-403A-8301-F74FB443500DQ36051811-B9D54E36-C89E-4B9F-9B44-D0FF0B3F25F9Q36380850-B37E6899-00F0-4033-ABE0-6FED9F758E12Q36380866-CAF2122E-E0B0-4A63-94F5-48B4BEEFC11AQ36842537-9B912515-D3C3-4073-8DE5-4CA2504D0D33Q36969983-405C6A1B-E2E6-4A4A-8E76-0173519F2E90Q37099175-AF272CC5-0F33-4B3C-A847-F211B1D484C6Q38707634-AD47D9DD-0515-49B5-82B2-49AFE443F11BQ38707642-BD791D3D-73D3-4CB9-BA41-1F2354298ACFQ38908405-F599862B-546B-450F-9D08-FD70D5F4A009Q39241636-ABBBD1A6-A188-4DDF-BFBA-C39C7DA94EEDQ39261756-91E93030-A307-4103-9CC6-3947E960F110Q40046833-2DAE80E3-B205-45D8-B999-603FBB2B5555Q40048236-92EA52F5-EEC1-4A54-89B7-8B513AD177F3Q41582076-438EE155-08F1-4687-A248-910EAEE92A41Q42274835-15B77756-FCB2-416F-9131-FE6BA1328E09Q43483660-D4B64E5E-179B-47F6-845A-EFB394CC3E3AQ43586054-48FA50E0-2C3A-4F74-B891-D1E5A6FD048EQ44198755-4BF54E66-290F-4B67-82D0-20577DA586B8Q44991499-D21BEE31-76B3-44A0-B38D-CC5CE1FEAACDQ45196369-8B04745A-FC33-40C7-8E4E-BD0853C65958Q46720961-7A4E41FF-320C-49DA-B5AB-6FF5883BD131Q47339569-85802FC1-0BB1-4ACB-BF7A-50DF50955D11Q47418652-F9894DCC-30CE-465A-B69E-A65C660BCC2CQ47658551-41F29A46-C7C8-4863-9540-AC11F89576A7Q47783770-2626B635-34E4-4D1D-8D64-F94737D7CAF9Q47792520-8CF78639-A5EB-493F-8F5C-C97A08C0DD12Q47869382-BB4EB479-A07B-4EE5-B180-295C0D747D01Q48059181-C20B257E-C204-4C88-A49E-A989BE931A2AQ50038704-77A62055-41A5-4ED1-9BD2-C46E24C771FBQ50666682-3758D9A4-9E05-4585-9CB2-6B91DD2915E8Q51108199-FA21E61E-2A21-4F3F-B7D4-44B71A21D092Q51152921-6E690694-3C90-4C4A-AAD2-7C42D9BD6BFEQ51261282-A57D5F33-015C-46EA-8FAC-5F74AD5222D7Q54293759-8307407A-1A45-44C5-8612-0CEEEB204384Q54396563-503E5730-8E3B-418B-A78C-266D1F74FBBDQ57802708-F7961B61-885F-4686-BE9F-6A76ABF98B13Q57822592-EBB27D74-0B4E-4C50-91A4-42581CE68405
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Matthew Shaw
@en
Matthew Shaw
@nl
type
label
Matthew Shaw
@en
Matthew Shaw
@nl
prefLabel
Matthew Shaw
@en
Matthew Shaw
@nl
P31
P496
0000-0001-9184-5591